Derbend Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$250K Sell
2023
Q4
$235K Buy
2023
Q3
Sell
2023
Q2
$234K Buy
2022
Q4
Sell
2022
Q3
$300K Sell
2022
Q2
$284K Sell
2022
Q1
$888K Hold
2021
Q4
$888K Sell
2021
Q3
$1.56M Buy
2021
Q2
$2.02M Buy